Bain Capital Life Sciences Investors, LLC
Position in KLRA — Kailera Therapeutics, Inc.
CIK 1703031
Boston, MA
Position in KLRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$497,509,394
New position
Shares Held
22,583,268
first reported quarter
Ownership
17.4%
of shares outstanding
% of Portfolio
29.58%
of 13F equity value
Holder Rank
#2
of 99 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. KLRA ranks #1 (37.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
This page
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in KLRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,509,394 | 22,583,268 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||